News

They found a new molecule named lariocidin—a potential new antibiotic with the power to kill some of the world’s most drug-resistant bacteria. The molecule belongs to a rare class called lasso ...
Amid a surge in drug-resistant bacteria, researchers believe they have discovered a new class of antibiotics, three decades since the last one came to market.
That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective at killing both gram-positive and gram-negative pathogenic bacteria, along ...
Bacteria can easily evolve, and can quickly gain resistance to drugs. Drug-resistant bacterial infections already cause the deaths of millions ... | Cell And Molecular Biology ...
The study reveals lariocidin, a potent ribosome-targeting antibiotic, with unique mechanisms that could combat drug-resistant ...
A team of researchers from McMaster University has identified a new molecule – lariocidin – that can challenge some of the most drug-resistant bacteria on Earth. The discovery responds to a critical ...
Lariocidin hits drug-resistant bacteria where others fail — by hijacking the ribosome at a new site, bypassing defences, and opening the door to a new generation of antibiotics. Lariocidin ...
Lariocidin binds directly to a bacterium's protein synthesis machinery in a completely new way, inhibiting its ability to grow and survive. "This is a new molecule with a new mode of action ...
Teams at McMaster University in Ontario, Canada and the University of Illinois, Chicago — led by researcher Gerry Wright — collaborated in the discovery of lariocidin, which was found to be ...
A team led by renowned researcher Gerry Wright has identified a strong candidate to challenge even some of the most drug-resistant bacteria on the planet: a new molecule called lariocidin.
A small molecule shaped like a lasso may be a powerful tool in the fight against infectious diseases. A small molecule shaped like a lasso may be a powerful tool in the fight against infectious ...
A team led by renowned researcher Gerry Wright has identified a strong candidate to challenge even some of the most drug-resistant bacteria on the planet: a new molecule called lariocidin.